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Knowledge of the cells potentiated  by adjuvants is of importance in under- 
standing their mode of action and in aiding delineation of the early, subliminal 
events  in the processes leading  to humoral  and cell-mediated  immunity.  Lab- 
oratory models for initiation  of antibody synthesis  incorporate  the  sequential 
action of several types of cells (1-3). A  speculative  role for the macrophage as 
initiator  of  this  sequence  is  postulated  inasmuch  as  exposure  of  antigen  to 
peritoneal  exudate  cells  (PEC) 1 before injection can either  initiate  or enhance 
such systems (1, 4-8). Although immunogenic activity was found to be present 
in ribonucleic acid-rich fractions from such peritoneal cells, a question exists as 
to  whether  antibody  synthesis  resulted  from  trace  antigen  combined  with  a 
nucleic acid structure  as  a  powerful adjuvant  (9),  or whether  the nucleic  acid 
was an induced mediator (10), or both were functional. Since defined homoribo- 
polynucleotide  complexes  such  as  polyadenylic-polyuridylic acid  (poly A:U) 
have been shown recently to act equally as well as nucleic acids as adjuvants in 
the stimulation of antibody synthesis in vivo  2 (11, 12), their capacity to increase 
the responsiveness  of PEC  exposed  to antigen  in vitro was investigated.  The 
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conclusion  that  the  PEC  may  be  one  of  the  cells  affected  by  the  homoribo- 
polymers is supported  by the data recorded herein.  In addition,  the capability 
of  ribonucleic  acid-rich  fractions  extracted  from  PEC  to  convey  immunity 
under  poly  A:U  stimulus  is  documented. 
Materials and Methods 
General.--Polyadenylic acid, potassium salt, (poly A, lot No. A-16744;  1104748) and po]y- 
uridylic acid, ammonium salt,  (poly U, lot No. 45750;  411754)  were purchased from Miles 
Laboratories, Inc., Elkhart, Ind. The polymers were prepared in a concentration of 3.0 mg/ml 
in 0.15  ~  NaC1 and frozen separately at  --20°C. These stock solutions were diluted  1:2 by 
mixing with each other to form the helical polvmer (poly A:U) and allowed to stand at 4°C 
for 30 min before use. A final concentration of 150/zg/ml of each was  used  unless  otherwise 
indicated. Oligonucleotides of adenylic acid, A3-A6 (Lots  12-5-392)  also were obtained  from 
Miles Chemical Laboratory, as was tritium-labeled poly A, specific activity 16 Ci/m~ poly- 
nucleotide  phosphorous  (Lot  57-23-303),  and  tritium-labeled  po]y  U,  specific  activity  36 
Ci/mM  polynucleotide  phosphorous,  (Lot  57-33-310).  Deoxyribonuclease  (DNAse)  and 
ribonuclease  (RNase) were obtained from Worthington Biochemical Corp.,  Freehold, N. J. 
Digestion of nucleic acids with nucleases was carried  out for 60  min at  37°C.  (DNAse 25 
/2g/mg DNA;  RNAse 9 #g/rag RNA).  Pronase  was  obtained  from  California Biochemical 
Corp., Los Angeles, Calif. It was self digested for 4 hr at 37°C, followed by dialysis for 18 hr 
against continually changing deionized water. Proteolytic activity was verified by solubiliza- 
tion of ethanol-precipitable bovine gamma globulin (BGG). Uridine 5-T3H, specific activity 
8-15 Ci/m~, was obtained from Nuclear Chicago, Chicago, Ill. Liquoflor was purchased from 
Pilot Chemical Company, Long Island City, N. Y. for use as the scintillator in the standard 
counting solution, Dioto]. Actinomycin D  (Hoffman-LaRoche, Inc., Nutley, N.  J.)  was dis. 
solved in 50% acetone and stored at  -20°C. 
PEC Isolation.--Macrophages (used synonymously with PEC) were isolated by a modifica- 
tion of the method of Gallily and Feldman (4). BALB/aj mice, 8 wk old, inbred in this de- 
partment,  were injected with 3.0 ml of thioglycollate medium. 4  days later the cells in the 
peritoneal cavity were washed  out with 8.0 ml of phosphate-buffered saline  (PBS), pH 7.2, 
(NaCI,  4.27  g/liter,  Na2HPO4,  8.10  g/liter;  KH2PO4,  2.45  g/liter)  containing  penicillin, 
streptomycin,  and  heparin  (100 units,  50 #g,  and  5  units  USP/ml respectively). The cells 
were centrifuged at 600  rpm for 10 rain  and  resuspended in 10 ml of Eagle's basal medium 
(BIV[E) containing  penicillin,  100  units/ml,  and  streptomycin,  50 #g/ml.  Purification was 
achieved by centrlfugation at 300 rpm for 10 min, removal by aspiration of the supernatant 
fluid and top 1-2 mm packed cells, resuspension  of the pellet in 10 ml PBS, pI-I 7.2, and repe- 
tition of  the centrifugation  2  times.  Finally,  the pellet was  centrifuged at  900  rpm  for  l0 
min, the supernatant fuid discarded, and five parts distilled water added  to the packed  cells 
with mixing to lyse red cells.  The cells were mixed for 20 sec, immediately  diluted  10-fold 
with BME, and counted in a  hemocytometer or after staining with Wright's stain. The  cell 
population was  routinely greater than 95%  macrophages and  contained approximately 1% 
lymphocytes. 
Preparation of Spleen Cells  from Mice.--Spleens were removed from 20 mice, washed with 
PBS,  pH  7.2,  and  extraneous  fascia and  connective tissue were  trimmed.  Four  spleens  at 
one time were minced in 10 ml PBS, pH 7.2, placed in a glass homogenizer (Potter-Evehjem), 
and  homogenized  20  strokes.  The  homogenate  was  passed  through  a  fine  mesh  screen, 
U.S. Bureau of Standards No. 80, and the cells were collected  by centrifugation at 1500 rpm 
for 10 rain. After washing 3  times with PBS, pH 7.2,  the red cells were lysed with a  20 sec 
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and the cells were centrifuged at 1500 rpm for 10 min. The pellet was resuspended in 40 ml 
BME  with  20%  calf  serum  containing penicillin and  streptomycin. Adherent cells  were 
separated from the spleen cell preparation by culture for 2.0 hr on Falcon plastic "T" flasks 
(Falcon Plastics, Los Angeles, Calif.)  with a  useable area of 30 cm.  2 The nonadhering cells 
were decanted, washed twice in BME minus serum, and added to monolayers of macrophages 
at 4.3  >(  l0  T spleen cel]s/ml. 
In  Vitro Incubation of Macrophages with Antigen, Uridine, and Poly A :U.--For uridine 
labeling,  4 ml of peritoneal macrophages (1-2  X  107/ml),  purified by centrifugation as de- 
scribed above, were placed in stoppered, siliconized  Erlenmeyer flasks  under an atmosphere 
of 95:5% air:CO2 in BME without serum, but containing penicillin and streptomycin. The 
cells were incubated with BGG and poly A:U for 30 min at 37°C with shaking before the 
addition of uridine, 5-T-all. 0.01 mC  1 contained in 0.002 #mole of uridine was added to each 
flask  and incubation carried out for an additional time period. Portions were removed into 
frozen, slushed PBS, pH 7.2, to stop uptake. The cells then were washed three times in PBS, 
pH 7.2,  and finally precipitated with 2 N-HCLO4 containing 1%  Dicalite in  ice.  After 30 
rain in ice the precipitate was centrifuged at 1000 rpm for 10 min and the pellet washed an 
additional three times with 5 ml 0.5 N-HCLO4.0.2 ml of 0.5 N-HCLO4 was added to the pellet 
and each was boiled for 5 min. The whole pellet was then transferred to counting vials with 
12 ml of Diotol scintillation fluid and counted in a model 3300 Packard scintillation counter 
(Packard  Instrument  Co.,  Downer's  Grove,  Ill.).  Control,  nonspecific absorption  values 
were measured also by adding equivalent amounts  of protein to the label after the addition 
of acid. Results were expressed as net cpm after subtracting background and control values. 
Replicate counts on separate samples were always within  4-  5%. 
For reinjection into mice, peritoneal macrophages were obtained and purified as described 
above. Incubation with antigen was carried out for 2 hr after which the cells  were washed 
four times with 50 volumes/ceU pack of cold BME at 1000 rpm for 20 min. The cells were re- 
suspended at 3-5 )<  107/ml  and 0.5  ml injected intraperitoneally into normal 7-8-wk old 
mice. Control mice also were injected with B GG and poly A:U in 0.5 ml without macrophages. 
Blood was collected on various days and the serum assayed by passive hemagglutination using 
sheep red cells sensitized with 3 mg BGG/ml 2.5% cells. 
Isolation of RNA from Macrophages.--Nucleic acids were prepared essentially free of pro- 
tein and containing no nucleotides or nucleosides by the method of Marmur (13) as modified 
for RNA by Adler et al.  (14). A 7.0 ml packed cell volume of purified macrophages, which 
had been stored at --20°C, was thawed in one volume of buffer solution, pH 5.0, containing 
10-~M MgC12, 0.2 ~  LiCI, 0.01 M acetic acid, and 0.01 ~  sodium acetate and 0.5% SDS. The 
mixture was shaken vigorously for 3 min after the addition of one volume of freshly distilled, 
water-saturated phenol. It was then heated at 60°C for 3 min, cooled rapidly, and centrifuged 
at 12,000 rpm for 30 min. The pellet was reextracted once with phenol and the aqueous phases 
combined. The aqueous phase was layered with six volumes of cold absolute ethanol, allowed 
to stand for 24 hr at  --20°C, and centrifuged at 17,000 rpm for 30 min. The pellet was re- 
suspended in 5 ml of buffer (0.02 M tris(hydroxymethyl)aminomethane  (Tris), pH 7.6, 10  -3 
MgC12, 0.2 M LiC1). The ethanol precipitation was repeated and the final pellet resuspended 
in the above buffer without LiC1. 20 mg RNA was digested with 100 #g/ml DNAse I  for 1 
hr at 37°C.  After DNAse treatment the RNA was precipitated by four volumes of absolute 
ethanol and centrifuged at 17,000 rpm for 60 min. The pellet was resuspended in the above 
buffer minus LiC1. This solution was then dialyzed overnight against 500 ml of buffer. 
RNA Prepared  for Sucrose Density Gradients and Biological Activlty.--To  obtain RNA for 
determination of a species of mRNA which could be quickly labeled by uridine, a modifica- 
tion of the method of Ralph and Bellamy (15) was used. Macrophages were induced with 
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A:U, the macrophages were washed four times with BME and resuspended in two volumes 
of buffer (0.15 M NaCI, 0.1 ~  ethylenediamine tetraacetate  (EDTA) containing 10  -3 •  MgC12 
plus 0.5% SDS). The cells were then homogenized for 20 strokes in a glass homogenizer, an 
equal volume of freshly distilled phenol was added, and the mixture was  shaken for 10 min 
at 25°C and stirred for 3 rain at 63°C. The aqueous phase  was removed after centrifugation 
at 1000 rpm for 15 rain. An equal vol of chloroform-isoamyl  alcohol was added to deproteinize 
the material, and after shaking for 10 min the mixture was centrifuged at 1000 rpm for 10 rain. 
This deproteinization was repeated three times. The aqueous phase was divided, and to one 
half was added four volumes of cold, absolute ethanol, and precipitation was  allowed for 24 
hr at  --20°C. The other half was treated for 60 rain with 1 mg self-digested Pronase/ml of 
nucleic acid. The Pronase treated material was deproteinized as above, and precipitated with 
absolute ethanol. Both precipitates were resuspended in small volumes of 0.2  M LiC1, 0.02 
i  Tris, pH 7.8, 10-3 M MgC12, arid concentrations determined by absorption at 260 m/l. 
Characterization of RNA by Density Gradient Centrijugation.  Molecular sizing of the newly 
synthesized RNA under the stimulation of antigen was accomplished by the use of sucrose 
buoyant density centrifugation methods. Linear  sucrose gradients were poured in  SW  40 
Spinco tubes (Beckman Instruments, Inc., Fullerton, Calif.)  95 ram, with a  total volume of 
12.5 ml containing 5  20% sucrose, 5 )<  10  -3 5t MgC12, 0.05 M Tris, pH 7.8, and 0.5% SDS. 
0.5 ml of RNA solution containing 1-3 mg RNA was layered on the top and the gradients 
were spun at 39,000 rpm for 150 rain at 20°C to keep the SDS in solution. After centrifugation 
the gradients were removed and 25-30 samples collected by catching drops from holes punched 
in  the gradient. The location of various sized molecules was determined by analyzing the 
absorbancy of each fraction at  260  m/~ and counting the total fraction in  12  ml of Diotol 
solution in a  Packard 3300 scintillation counter. 
Trace Iodination of BGG.~he ch]oramine-T method of McConahey and Dixon (16) was 
used and specific acivities of 2-40 mCi/mg protein were obtained. 
Passive Rosette Assay.--The red cell rosette test (17, 18), as adapted for protein antigens 
by R. D. Stout (Ph.D. thesis. 1970. The University of  Michigan), was used to characterize 
the kinetics of antibody-forming cell populations in the spleen during the immune response of 
mice to BGG or macrophage RNA. Sheep red blood cells  (SRBC) were washed three times 
in PBS, pH 7.2,  and resuspended to a  50% concentration. 0.5  mg (100 mg/ml) ECDI  (1- 
ethyl-3-(3-dimethylaminopropyl) carbodiimide-HCl)  obtained from  the Ott  Chemical  Co. 
Muskegon, Mich., was added to 3 ml BGG (15 mg/ml) and 0.1 ml 50% SRBC. The mixture 
was incubated for 60 rain at 4°C, then centrifuged at 1500 rpm for 15 min. The red cells were 
washed twice in 1.0% normal rabbit serum in PBS, pH 7.2. Finally the cells were re-suspended 
at a  concentration of 7.0%  (19).  Accuracy of  the rosette assay was maintained when the 
number of  rosettes counted varied between 20  and  200. The concentration of spleen cells 
used was 1-10  ;<  106/ml. 0.1 ml of 7.0% sensitized SRBC cells was added to a 51  X  60 mm 
tube containing the test spleen cells. The tubes were incubated at a 45 ° angle for 2 hr and 
overnight at 4°C.  The rosettes were counted in a  hemocytometer and the final spleen cell 
count was determined by lysing SRBC in 2% acetic acid.  The results are expressed as the 
number of rosette-forming cells  (RFC)  per 106  spleen cells. 
RESULTS 
The Adjuvant  Action  after Exposure  of Antigen  to  Macrophages  and its En- 
hancement by Homoribopolymer Complexes.--When  macrophages isolated from 
the peritoneal exudate  of  thioglycolate-treated, normal mice were exposed in 
vitro to BGG and reinjected into syngeneic mice, a  shortened induction period 
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rectly with  antigen.  Representative  data  are  shown  in  Table I. Addition  of 
poly A:U to the incubation mixture further increased these titers. Additional 
experiments established that both 2-mercaptoethanol-sensitive and insensitive 
antibody  titers  were  elevated  by  exposure  of  antigen  to  macrophages  and 
poly A:U. The adjuvant action of the double helix made up of the homoribo- 
polymers, polyinosinic and polycytidylic acids  (poly I:C),  also was tested  in 
this  system,  and  these  complexes exerted  a  similar  enhancing  capacity over 
and  above that produced by antigen  alone when  added  to macrophages. 
The  relationship  between  decreasing  numbers  of  macrophages  incubated 
with  antigen  and  the  magnitude  of  the  stimulation  of  antibody  synthesis  is 
seen in Table II. A  drastic reduction in the effect was observed when the cell 
TABLE I 
The Adjuvant  Action  of Antigen  Exposure  to  Macrophages  and  its  Further  Enhancement  by 
Poly A : U 
Antibody Titer 
Mixture injected*  Days after injection 
6  8  10 
Macrophages only  0  0  0 
BGG only  80  320  640 
BGG +  Poly A:U  160  2,560  10,240 
Macrophages +  BGG  320  5,120  10,240 
Macrophages +  BGG +  Poly A: U  640  10,240  40,960 
Macrophages +  Poly A:U  0  0  0 
* Macrophages, 2.4 X l0  T  per mouse; B GG, 0.5 mg; and Poly A: U, 150 #g of each polymer, 
were incubated together (or separately as controls) for 2 hr with shaking, washed 4 times, and 
reinjected intraperitoneally into syngeneic mice. Antibody levels are the reciprocal of the 
passive hemagglutination titer, determined 6, 8, and 10 days after injection of recipient mice. 
population was decreased from 107  to  106/ml,  a  fact also recorded by others 
(4,  20).  A  minimal  number  of  107  macrophages,  necessary  for  eliciting  in- 
creased  antibody  synthesis  by  macrophages  and  antigen  without  adjuvant, 
was also necessary for the further adjuvant action of homoribopolymers. This 
suggested that poly A:U was increasing a process required  to be initiated  by 
an adequate number of macrophages and was not merely additive to the macro- 
phage effect. The injection  of  105  cells/ml suppressed  the  response and  poly 
A:U was unable to stimulate  105 macrophages exposed to 0.5  mg of BGG to 
evoke an enhanced response in mice. This was despite the fact that poly A:U, 
when  injected  in vivo with  antigen,  was capable of stimulating  an  antibody 
response to as little as 1 ng of BGG3 Thus, a level of transfer or concentration 
of antigen below 10  -9 g BGG by 105 macrophages was indicated. It had been 
shown  previously  ~ that  a  single  injection  of poly A:U  1  day before  antigen 654  POLYNUCLEOTIDE  REGULATION  OF  THE  IMMUNE  SYSTEM.  II 
suppressed rather than enhanced antibody synthesis. To test whether this im- 
munosuppression might be due to a  defect in macrophage handling of antigen 
in vivo induced by prior injection of poly A:U, macrophages were removed from 
mice injected with poly A:U 18 hr before harvesting (2 days after thioglycolate). 
TABLE II 
Titration  of Numbers  of Macrophages Required Jbr Adjuvant Action 
Mixture injected* 
Antibody Titer 
Days after injection 
7  10 
BGG only 
BGG +  Poly A:U 
Macrophages,  5.0 ;< 107 -[- BGG 
Macrophages,  5.0 >(  107 -[- BGG +  Poly A:U 
Macrophages,  5.0 X  106 +  BGG 
Macrophages,  5.0 >( 106 +  BGG +  Poly A:U 
Macrophages,  5.0 X  105 +  BGG 
Macrophages,  5.0 )<  105 +  BGG +  Poly A:U 
1,280  5,120 
2,560  10,240 
10,240  10,240 
20,480  40,960 
80  80 
40  40 
0  0 
0  0 
* BGG, 0.5 mg; Poly A:U, 150/zg each. Incubation as in Table I. 
TABLE III 
Loss  of Adjuvant Action  of Macrophages after Pretreatment  o  j" Mice with  Homoribopolymers 
Hemagglutination titer 
Mixture injected*  Days 
6  8  10 
BGG  40  160  320 
BGG +  Poly A:U  80  640  640 
Macrophages +  BGG  160  1280  2560 
Macrophages -- BGG +  Poly A:U  640  5120  20480 
Macrophages~+ BGG 
Macrophages{  +  BGG+ PolyA:U 
40  320  320 
80  160  320 
* BGG, 0.5 mg; poly A:U, 150 #g/ml each; macrophages, 4.4 X  107/ml. Incubation as in 
Table I. 
Macrophages obtained from mice injected with 300 #g poly A:U 18 hr before harvesting. 
The results (Table III) supported this hypothesis in that these PEC were found 
to have lost the capacity to enhance antibody synthesis. 
The  act  of inducing  a  sterile peritonitis by injecting thioglycolate medium 
into  the mouse  might  give rise to  PEC  with  abnormal properties.  Such  ceils 
could have been stimulated to a high degree by the presence of the irritant, or 
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repeated experiments the injection of 4 ml of sterile pyrogen-free PBS, pH 7.2, 
resulted in PEC  which  also were capable of similar enhancement of antibody 
synthesis,  despite being smaller  and  100-fold less in  number per  mouse  than 
those induced  with  thioglycolate.  It was  concluded  that  saline-induced  PEC 
do not differ in adjuvant properties from thioglycolate-induced cells. A  similar 
conclusion was reached by Mitchison (8). 
Evidence has accumulated recently that the interaction of two or more cells 
may be required for antibody synthesis in response to some antigens (2, 3). To 
TABLE  IV 
Effect  of Interaction  of Competent Macrophages with Spleen  Nonadhering  Cells 
HA antibody titer 
Incubation mixture injected  Days after inoculation 
6  8  10 
BGG  80  320  160 
Reisolated spleen cells after  interaction  with  2560  1280  1280 
competent macrophages 
Macrophages  incubated  with  BGG  without  1280  1280  320 
spleen cells 
Concentrations: BGG (agg), 0.5 mg; macrophages,  5 X 107/ml; spleen cells, 4.3 X 107/ml. 
TABLE  V 
The Effect of BGG and Poly A : U on the Uptake of 3H-Uridine  into  Macrophages 
Mixture* 
Net CPM into RNA 
15 min  60 min 
Macrophages 
Macrophages +  BGG 
Macrophages +  Poly A:U 
Macrophages +  BGG +  Poly A:U 
8796  16123 
12374  19202 
10766  18022 
15552  23472 
* Macrophages, 2 X  107; BGG, 0.5 mg; Poly A:U, 150 #g each. 
determine  if  macrophages  exposed  to  antigen  could  transfer  their  adjuvant 
capabilities  to  another  cell,  the  following  experiment was performed.  Mono- 
layers  of  macrophages were  prepared,  aggregated  BGG  was  added,  and  the 
mixture was incubated for 30 min. The macrophages were washed four times 
and purified spleen, non-glass  adhering ceils were added over the macrophage 
monolayer. The cells were allowed to interact for 2 hr after which  the nonad- 
hering spleen cells,  which were 90 % lymphocytes, were decanted,  washed four 
times,  resuspended,  and  injected  into  normal mice. Table IV shows  that  the 
lymphocyte-rich  population  indeed  had  acquired  the  capacity  of  provoking 
an  enhanced  antibody response as  compared to  antigen  injected  alone.  Inas- 656  POLYNUCLEOTIDE REGULATION O:F  THE  IMMUNE  SYSTEM.  11 
much as the data in Table II indicated  that less  than  107 macrophages were 
incapable of enhancing antibody synthesis, it is unlikely that the effect was due 
to  contamination  of  the  lymphocytes with  macrophages.  Macrophages  ex- 
posed to antigen which did not have any spleen cells added to them remained 
capable of adjuvant action, as expected. However, in control tests, the medium 
alone in which only macrophages had been incubated was not able to induce 
circulating  antibody,  indicating  there  had  been  no  detectable  release  of  im- 
munogenic factors into the medium. The effect of poly A:U on these experi- 
ments is under study. 
Nature  of  the  Material  Stimulated  in  Macrophages.--If  de  novo  synthesis  of 
RNA  were  a  molecular  event  in  cells  that  followed  recognition  of  nonself 
molecules,  an increase in uridine uptake into RNA should have been  apparent 
TABLE VI 
The Ej~ect of Actinomycin D on the Adjuvant Action of Peritoneal  Maerophages  with BGG and 
Poly A : U 
Incubation mixture injected* 
HA antibody titer 
7 days  9 days  11 days 
Macrophages only 
BGG only 
BGG +  Poly A:U 
Macrophages +  BGG 
Macrophages +  BGG +  Poly A:U 
Macrophages +  BGG +  ActD 
Macrophages +  BGG +  Poly A:U -t- Act D 
0  0  0 
10  20  10 
320  640  1280 
160  320  320 
640  1280  5120 
20  10  20 
80  160  640 
* Concentrations: macrophages, 2.4 X  107 per mouse; BGG, 0.5 mg; poly A:U, 150 #g 
each; actinomycln D (Act  I)), 15/~g. 
when macrophages were incubated in the presence of antigen. This  correlation 
did exist,  as is shown in Table V. When BGG and poly A:U were added in com- 
bination,  a  doubling of the  uptake  of label  occurred. In addition,  poly A:U 
without antigen was capable of causing a  stimulation  in  the  uptake  of label 
into RNA. The optimum concentration of BGG effective at increasing uridine 
labeling  was  found  to  be  0.5-1  mg/ml,  while  0.25  mg/ml  had  little  effect. 
Inhibition was seen with  2 mg/ml.  The optimum concentration  of poly A:U 
resulting in maximum uptake appeared to be 150-300 ~g/ml; little  stimulation 
occurred at  75 /~g/ml.  No further  increase  in stimulation  could be  seen  with 
poly A: U  concentrations up  to 2400/~g/ml.  Relative values  similar  to those 
shown in Table V were obtained repeatedly. 
To determine  any possible  relationship  of  this  newly synthesized RNA to 
messenger RNA, actinomycin D  was added to the macrophages in culture be- 
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macrophages were washed four times to insure that the level of carry-over of 
residual  actinomycin D  into  the  mouse was far below the  value of  10  tzg of 
actinomycin D  per mouse, shown by Wust et al. (21)  to have no effect on sub- 
sequent antibody synthesis. It can be seen in Table VI that 15 tzg of actinomycin 
D  effectively blocked the ability of the macrophage to enhance antibody syn- 
thesis,  thus  suggesting  that  the  role of the  macrophage includes  synthesis of 
messenger RNA. Of interest is the fact that actinomycin D  inhibition was re- 
versed by poly A:U when the latter was given either directly before or after 
this  inhibitor.  Jaroslow  (22),  using  RNA-RNAse  digests,  showed  a  similar 
inhibition by actinomycin D  of antibody synthesis in rat lymph node cultures. 
Study of the  effect of the  time of addition  of actinomycin D  during  the in 
TABLE VII 
Effect of Time of Addition of Actinomycln D to Macrophage-Antigen Mixtures 
HA antibody titer 
Incubation mixture injected  Act D  added  Days after inoculation 
6  8  10 
rain. 
BGG  --  160  640  320 
Macrophages +  BGG  --  640  2560  2560 
Macrophages +  B GG  0  0  0  0 
Macrophages +  BGG  15  40  80  160 
Macrophages +  BGG  30  20  160  320 
Macrophages +  BGG  60  20  160  320 
Macrophages +  BGG  120  640  640  320 
Macrophages +  BGG 0.5 mg added at time of injection  0  320  320  640 
Concentrations: BGG (agg), 0.5 mg; macrophages,  2.5 X 107/ml; Actinomycin  D (Act D), 
15/~g/ml. 
vitro  incubation  of  macrophages  with  antigen  confirmed  that  complete  in- 
hibition occurred if actinomycin D  was added at zero time; however, if actino- 
mycin D  was delayed for only 15 rain after antigen had been added, some RNA 
was  synthesized,  as  denoted  by measurable  antibody  titers  (Table  VII).  If 
the drug were added at 120 min, antibody titers were comparable to those seen 
with antigen injected without macrophages. The data shown in the last line of 
Table VII represents the  control mixture. In this sample actinomycin D  was 
added  at zero  time  and  the  mixture was  incubated  without  antigen  for  120 
rain. After washing the macrophages and resuspending them in PBS, pH 7.2, 
antigen was added immediately before injection.  If inhibitory concentrations 
of actinomycin D  were carried over to the recipient mouse, antibody synthesis 
should have been inhibited in these mice. Since it was not, it was concluded that 
the  adjuvant  action  of  macrophages required  metabolically  active  cells  and 
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this  experiment  that  the  required  messenger  RNA  was  coded  for  immuno- 
globulin synthesis. 
The nature of the newly synthesized macrophage RNA was examined further 
by  comparing  the  distribution  of  macrophage  RNA  from  macrophages  ex- 
posed or not exposed to antigen  after  sucrose buoyant-density centrifugation. 
A marker (poly A) with a known S value of eight was included in the gradient 
so  that  relative  S  values  could  be  assigned  to  the  RNA  synthesized  under 
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FIG. 1. The distribution of macrophage RNA after antigenic stimulation in vitro by BGG. 
The RNA was isolated by hot phenol. Gradients were composed of 5-20% sucrose containing 
5 X  10-3M MgC12; 0.05 ~I Tris, pH 7.8; 0.5% SDS, and was centrifuged at 39,000 rpm for 
150 min. The tubes were divided into 20 fractions and each was analyzed for radioactivity 
and A260. 
antigenic stimulation.  From Fig.  1 it may be seen that there was a shift of 16S 
ribosomal  RNA  to the  smaller  4S  RNA  when  macrophages  were  exposed  to 
antigen. The latter RNA, however, would be of insufficient size to be messenger 
RNA. 
The  immunologic  competency of  this  newly  synthesized  RNA  was  tested 
following its  isolation  by phenol.  The RNA-rich material  (termed  RNA)  iso- 
lated under these conditions proved occasionally to be toxic for mice, and only 
small amounts were tolerated.  All attempts  to effect an antibody response by 
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which RNA was treated with the self-digesting enzyme, Pronase, in an attempt 
to eliminate any response by removing antigenic  fragments postulated as being 
attached to the nucleic acid. On the other hand,  when poly A:U was added to 
the RNA at the time of injection, antibody titers detectable by passive hemag- 
glutination  were  elicited.  Table  VIII shows  results  representative  of six  dif- 
ferent positive  experiments.  In instances  where  la~I-labeled BGG was used  as 
antigen,  antigenic retention measured isotopically was found to  be  0.1  ng/ml 
or less after the isolated RNA was treated with Pronase. Consequently, by this 
technique the greatest amount of antigen given with RNA to any given mouse 
appeared to be on the order of 10  -:1 g. Yet this RNA was immunogenic, capable 
of eliciting  a slight,  but reproducible  and specific antibody response under the 
TABLE VIII 
Induction  of Rosette-Forming Cells and Hemagglutination Antibody  after Injection with 
Macrophage RNA 
Condition 
No. of  HA antibody titer 
rosettes 
per 10~  Day 
spleen cells 
Day 4  6  32  35  38 
BGG  7,800  40  10  0  10,240 
RNA 0.070 mg  6,500  0  0  0  2 
RNA 0.070 mg ~- Poly A:U  10,000  8  0  0  16 
P-RNA 0.063 mg  5,500  4  0  0  32 
P-RNA 0.063 mg q- Poly A:U  9,600  16  0  0  64 
P-RNA 0.063 mg q- RNAse  1,200  0  0  0  20 
Control  1,400  0  -  --  -- 
Concentrations:  BGG,  0.50 rag; poly A:U, 150 #g/ml each;  RNAse, 25 
incubated  60 rain  at 37°C. All mice, except control  group, were reinjected 
BGG on day 32. P-RNA represents RNA treated with Pronase. 
#g/mg RNA; 
with  0.50 mg 
stimulation of poly A:U. The effectiveness of this immunogenicity is to be com- 
pared  with  10  -s g  of antigen found as required  to be retained  in preliminary 
experiments  for detectable  antibody synthesis  after  exposure  to viable  whole 
macrophages and poly A:U. 
Since  the  titers  of  antibody  induced  by  macrophage  RNA  were  low,  the 
numbers  of rosette-forming cells in the spleen were also measured  after  RNA 
injection.  The RFC  appearing on day 4  are compared in Table VIII with the 
antibody titers appearing 2 days later in other groups of similarly injected mice. 
It may be  seen  that  the  RNA induced  RFC  comparable  in  number  to those 
stimulated  by injection  of  BGG  alone.  Again,  poly A:U  given  with  RNA 
elevated the RFC in comparison to RNA alone. It also may be seen that RNAse 
digestion  of  the  RNA  preparation  completely  reduced  the  RFC  to  control 
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were incapable of responding  to a  second injection  of antigen  with  a  typical 
secondary  antibody  response.  All  RNA-injected  mice  showed  low  levels  of 
circulating  antibody on day 38,  6 days after reinjection of BGG, in contrast 
to the group initially injected with antigen rather than RNA, which showed a 
titer of 10,240.  Because none of the animals primed with RNA even approached 
this level on reinjection of antigen,  any antigenic fragment,  if present in  the 
RNA, differed either quantitatively or qualitatively from the original antigen 
in capacity to prime for a secondary response. Table IX records one of the con- 
firmatory experiments in which  the  background  count  of RFC  was down  to 
lower  levels,  495  RFC/106  spleen cells.  In  this  experiment  again,  the  RNA- 
rich  preparation  which  had  been  digested  with  Pronase  was  able  to  induce 
RFC  comparable in  number  to  the  RFC  induced  by injected  antigen  alone. 
TABLE IX 
Induction of Antibody Synthesis  by an RNA-Rich Fraction Isolated fro m Macrophages 
Material injected  RFC/'106 
spleen cells 
HA antibody titer 
Day 6  Day 35 
B GG  6,400  40  20,480 
RNA, 0.1 nag  2,000  0  40 
RNA, 0.1 mg -t- poly A:U  5,250  2  40 
RNA,* 0.2 mg  5,300  4  20 
RNA,* 0.2 mg q- poly A:U  8,700  16  320 
Control  495  0  ND 
Concentrations: BGG, 0.5 mg; poly A:U, 150 #g each/ml. RFC measured on day 6 after 
injection. All mice injected with BGG 30 days after initial injection of BGG or RNA. 
ND  =  not done. 
*RNA treated with Pronase. 
Poly A:U  was  able  to  elicit  greater  numbers  of RFC/106  spleen  cells  than 
RNA without  the  adjuvant,  and once again,  the secondary response in these 
RNA-induced  mice  was  much  less  than  that  seen  in  mice  stimulated  with 
antigen alone. 
DISCUSSION 
The macrophage limb of the immune system aiad its role as a possible locus 
for the enhancing action of poly A:U was investigated in these experiments. A 
possible function for  the  macrophage in antibody synthesis  became  apparent 
from  the  experhaaental  model  developed  by  Fishman  (1).  With  this  model, 
anti-T2  phage antibody was elicited by incubating  an RNA-rich preparation 
from rat  peritoneal  exudate  cells  exposed  to  antigen  with  lymph node  cells. 
Although in confirmatory studies by others (23-25), it was shown that similar, 
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anti-phage antibody; in further experiments (10),  three fractions with approxi- 
mate  S  values of 4-5,  16,  and  23-28  could be separated  on sucrose density 
gradients from the  RNA  preparation,  and  antigen was  detected only in  the 
heavy RNA. The antibody response was biphasic with a peak of 19S antibody 
elicited by the light RNA at 2 days and a peak of 7S antibody evoked by the 
heavier RNA at 11 days. Thus, it was suggested that only the activity of the 
heavy RNA  fraction was  dependent  on  the  presence of  antigen  or  antigen 
fragments. 
The  chemical nature  of  the  RNA-antigen  complex has  been  explored by 
Roelants and Goodman (26)  and by Gottlieb (27), with disagreement as to its 
general biological significance. However, the immunogenie activity of antigen 
bound to RNA was much greater than that of free antigen irrespective of how 
it was achieved. The existence of RNA-antigen complexes in mouse liver had 
been established  earlier by Garvey and  Campbell  (28),  and  these complexes 
likewise proved to be more efficient than the original antigen. Thus, the poten- 
tiality of poor immunogens (e.g. viruses and tumor antigens) made much more 
efficacious by combination in vitro with cellular RNA, is an important offshoot 
of these and  our studies,  even though  an  active processing or concentrating 
role of the macrophage in antibody formation in vivo has not yet been proven. 
The possibility that the light RNA was an informational macromolecule was 
raised in the experiments of Adler et al.  (14)  who incubated RNA extracted 
from peritoneal cells of rabbits of  one  allotype with  lymph  node fragments 
removed from rabbits of a different allotype. The resulting antibody produced 
by the lymph node fragments proved to be of the same allotype as the donor 
of the peritoneal cells. However, in our study, as well as several others (10, 26, 
29) the active RNA extracted from macrophages has been estimated to be too 
small to direct the synthesis of either a light orheavy immunoglobulin chain. 
Using the findings decribed above as a guide, the phases at which the poly- 
nucleotide adjuvants might be operative were tested. Our data show that an- 
tigenic stimulation of macrophages caused an increase in uridine uptake which 
could be furthered by poly A: U. Each increased RNA synthesis correlated with 
elevated antibody levels. Actinomycin D  established  that viability and  syn- 
thesis of messenger RNA were necessities for the adjuvant action of this ad- 
herent cell. This confirmed the finding of Bishop et al.  (29), but is to be dis- 
tinguished from the chemical study of Gottlieb (27),  in which actinomycin D 
failed to impair formation of the RNA-antigen complex. However, mere incuba- 
tion  of  RNA  from normal  macrophages  not  exposed  to  antigen  with  small 
amounts of free antigen did not result in a complex being formed. 
From the data in Table VII, it is evident that less than 15 min exposure to 
antigen and poly A: U was required for whatever macromolecular synthesis was 
necessary for enhancement. However, our sucrose buoyant-density centrifuga- 
tion  experiments  showed  the  biologically  active,  transferrable  RNA  to  be 662  ~POLYNUCLEOTIDE REGULATION OF  THE  IMMUNE  SYSTEM.  II 
primarily of the 4S size, indicating the required messenger RNA was not syn- 
onymous with this entity. 
Surprisingly, the 4S RNA after injection in mice was able to induce a measure- 
able,  specific  antibody  titer,  as  well  as  rosette-forming cells,  if  treated  with 
Pronase and stimulated by poly A:U. It is of interest that Fishman and Adler 
(10)  reported abolition of late antibody synthesis by the heavy RNA, but not 
the early 19S  antibody synthesized by the 5S RNA,  when both were treated 
with  Pronase.  Contamination  of  our  RNA  with  isotopically  labeled  antigen 
was below the level of 10  -n  g, but further data are necessary to support the 
possibility that  antibody formation was not initiated  by antigenic fragments. 
Data supportive of the hypothesis that macrophages can synthesize information 
RNA after stimulation by antigen has been recorded in a  series of important 
studies  by Jacherts  (30).  In these experiments,  19S anti-phage antibody syn- 
thesis  was  initiated  both  in  spleen  cell  cultures  and  in  a  cell-free system by 
several sizes of RNA. 
SUMMARY 
Incubation  of antigen  with  normal mouse peritoneal exudate  cells in  vitro 
and subsequent reinjection of the washed cells into syngeneic mice resulted in 
increased  antibody  titers  as  compared  to  mice  injected  with  antigen  alone. 
Several of the variables influencing this system were studied with and without 
the  stimulus  of complex homoribopolynucleotides (poly A: U  or poly I: C)  as 
adjuvants to determine the cellular site of action of the latter. It was found that 
addition of poly A: U  or poly I: C caused a further rise in circulating antibody 
levels  which  correlated  with  increased  RNA  synthesis,  suggesting  that  the 
macrophage was one cell affected by this adjuvant. Actinomycin D  was found 
to inhibit the rise in titer induced by PEC and this inhibition could be overcome 
by poly A :U. Injection of the polynucleotides 18 hr before antigen resulted in 
depression of circulating antibody levels, and poly A:U or poly I:C injected 18 
hr before harvesting PEC and incubation with antigen also inhibited the capac- 
ity of the  PEC  to increase  antibody levels. 
A  4S  RNA-rich fraction was purified after treatment with  phenol  of PEC 
exposed to antigen in vitro, and under the stimulus of poly A:U this RNA was 
capable of inducing specific antibody titers and rosette-forming cells on injec- 
tion  into  mice.  Antigen  contamination  of  Pronase-treated  RNA,  active bio- 
logically, was below 10  -11 g  as determined isotopically. 
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